Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme (Q44261654)

1 December 2017

title

Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme (English)

1 reference

adaptive radiation therapy

1 December 2017

main subject

0 references

1 reference

Lutterbach J

1

1 reference

1 December 2017

Weigel P

series ordinal

2

1 reference

1 December 2017

Guttenberger R

series ordinal

3

1 reference

1 December 2017

Hinkelbein W

series ordinal

4

1 reference

1 December 2017

publication date

1 October 1999

1 reference

Radiotherapy and Oncology

1 December 2017

published in

1 reference

1 December 2017

volume

53

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

49-52

1 reference

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Impact of spinal cord repair kinetics on the practice of altered fractionation schedules

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Accelerated hyperfractionated radiotherapy for malignant gliomas

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases)

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18 years--an analysis of 1,714 consecutive patients

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Radiation response of the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Therapeutic irradiation and brain injury

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Brain tumor survival: results from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

Altered Fractionation: Radiobiological Principles, Clinical Results, and Potential for Dose Escalation

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(99)00128-0

7 January 2021

10.1016/S0167-8140(99)00128-0

Identifiers

DOI

1 reference

1 December 2017

1 reference